Avanzanite Bioscience: Funding, Investors & Team (Sep 2026)
Avanzanite Bioscience enhances access to orphan drugs in Europe, partnering with pharma for rare disease treatments.
Avanzanite Bioscience has raised $37.1M across 1 funding round on record, the most recent a Series A of $37.1M announced in Nov 2025.
That round is above the $3.5M median round size for The Netherlands companies tracked on FundedIQ over the last two years.
Avanzanite Bioscience Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Avanzanite Bioscience Funding Rounds
Avanzanite Bioscience Founders and Leadership Team
Contact details for the Avanzanite Bioscience team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Avanzanite Bioscience Funding in Context
Avanzanite Bioscience's latest round of $37.1M is above the median round in The Netherlands. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Avanzanite Bioscience in Pharmaceuticals and Amsterdam
Companies Similar to Avanzanite Bioscience
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous…
Jianersheng Pharmaceutical is a manufacturer of heavy metal detoxification drugs.
AI-native back office platform automating business banking, accounting, and tax for founders.
World's first AI Hearing Health Platform
Kynexis is advancing the first potential precision medicine for the treatment of cognitive impairment…
Ore Energy develops long-duration energy storage systems for renewable energy applications and electric power…
Yanara is a renewable energy company that builds, owns, and operates utility scale hybrid power plants.
Tempress Systems, Inc. develops and manufactures horizontal and vertical diffusion/atmospheric and low…
Get your brand mentioned by AI search engines.
Nopan is a specialized Payment Service Provider built to optimize European account-to-account and digital…
Aardaia is leading the way in a new era of domestication on demand.
ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients…
Avanzanite Bioscience Funding FAQs
What does Avanzanite Bioscience do?
Avanzanite Bioscience enhances access to orphan drugs in Europe, partnering with pharma for rare disease treatments.
How much funding has Avanzanite Bioscience raised?
Avanzanite Bioscience has raised $37.1M across 1 round on record. The most recent is a Series A of $37.1M announced in Nov 2025.
When did Avanzanite Bioscience last raise funding?
Avanzanite Bioscience's most recent funding round on record is a Series A of $37.1M, announced in Nov 2025.
Who founded Avanzanite Bioscience?
FundedIQ lists Adam Plich (Founder) at Avanzanite Bioscience.
Where is Avanzanite Bioscience headquartered?
Avanzanite Bioscience is based in Amsterdam, The Netherlands.
How many employees does Avanzanite Bioscience have?
Avanzanite Bioscience is in the 11-50 employee band.
About FundedIQ's Avanzanite Bioscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Avanzanite Bioscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.